MORRIS PLAINS, N.J., Jan. 25, 2013 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that it will host a conference call and live audio webcast on Friday, February 8, 2013 at 10:00 a.m. Eastern Time to discuss financial results for the second quarter of fiscal year 2013, and review key clinical developments and future planned activities.
